SWS1
Product Specifications
CAS Number
2922115-32-8
Target
PD-1/PD-L1, Monoamine Oxidase
Related Pathways
Apoptosis, Neuroscience, Immunology/Inflammation, Cell Cycle/Checkpoint
Bioactivity
SWS1, a d- (+) -biotin-conjugated PD-L1 inhibitor (IC50: 1.8 nM), displays anticancer activity by augmenting tumor-infiltrating lymphocytes and demonstrating anti-tumor efficacy, as evidenced by a 66.1% tumor growth inhibition (TGI=66.1%) in the B16-F10 mouse model [1].
Smiles
C(CCCC(NCCNC(=O)C1N(CC2=C(OCC3=CC(C#N)=CC=C3)C=C(OCC4=C(C)C(=CC=C4)C5=CC=CC=C5)C(Cl)=C2)CCCC1)=O)[C@H]6[C@@]7([C@](CS6)(NC(=O)N7)[H])[H]
Molecular Formula
C47H53ClN6O5S
Molecular Weight
849.48
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6464572-01 0.1 mL
Aurora C, ID (Aurora/IPL1/Eg2 Protein 2, Aurora/IPL1-related Kinase 3, Serine/Threonine Protein Kinase 13, Aurora-related Kinase 3, ARK-3, Aurora Kinase C, Serine/Threonine-protein Kinase Aurora-C, AURKC, AIE2, AIK3, ARK3, STK13) (MaxLight 750)
Sign In for Pricing
View Details MBS6464572-02 5x 0.1 mL
Aurora C, ID (Aurora/IPL1/Eg2 Protein 2, Aurora/IPL1-related Kinase 3, Serine/Threonine Protein Kinase 13, Aurora-related Kinase 3, ARK-3, Aurora Kinase C, Serine/Threonine-protein Kinase Aurora-C, AURKC, AIE2, AIK3, ARK3, STK13) (MaxLight 750)
Sign In for Pricing
View Details